A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.

MLA

Hummel, Trent, et al. “A Pilot Study of Bevacizumab-Based Therapy in Patients with Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas.” Journal of Neuro-Oncology, vol. 127, no. 1, Mar. 2016, pp. 53–61. EBSCOhost, https://doi.org/10.1007/s11060-015-2008-6.

APA

Hummel, T., Salloum, R., Drissi, R., Kumar, S., Sobo, M., Goldman, S., Pai, A., Leach, J., Lane, A., Pruitt, D., Sutton, M., Chow, L., Grimme, L., Doughman, R., Backus, L., Miles, L., Stevenson, C., Fouladi, M., & DeWire, M. (2016). A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas. Journal of Neuro-Oncology, 127(1), 53–61. https://doi.org/10.1007/s11060-015-2008-6

Chicago

Hummel, Trent, Ralph Salloum, Rachid Drissi, Shiva Kumar, Matthew Sobo, Stewart Goldman, Ahna Pai, et al. 2016. “A Pilot Study of Bevacizumab-Based Therapy in Patients with Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas.” Journal of Neuro-Oncology 127 (1): 53–61. doi:10.1007/s11060-015-2008-6.